Mechanisms and treatment of the "afternoon phenomenon" in patients with type 1 diabetes mellitus using glargine as basal insulin

被引：0
|
作者：
Rossetti, P
Porcellati, F
Fanelli, CG
Bolli, GB
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [31] Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir
    Alvarez Guisasola, F.
    Mauricio Puente, D.
    Garcia Coscolin, T.
    Betegon Nicolas, L.
    Rubio-Terres, C.
    AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 430 - 435
  • [32] Lixisenatide as add-on to insulin glargine for the treatment of type 2 diabetes mellitus
    Forst, Thomas
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1703 - 1708
  • [33] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    DIABETES, 2014, 63 : A232 - A232
  • [34] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [35] Intensification of Basal Insulin Treatment Among Patients with Type 2 Diabetes Mellitus in the Netherlands
    Overbeek, Jetty A.
    Houben, Eline
    Kring, Sofia I.
    Briers, Jonathan
    Beest, Fernie J. A. Penning-van
    Van der Heijden, Amber A. W. A.
    Nijpels, Giel
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 77 - 77
  • [36] INTENSIFICATION OF BASAL INSULIN TREATMENT AMONG PATIENTS WITH DIABETES MELLITUS TYPE 2 IN THE NETHERLANDS
    Overbeek, J.
    Houben, E.
    Kring, S.
    Sommer, J.
    Penning-van Beest, F.
    van der Heijden, A.
    Nijpels, G.
    Herings, R.
    VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
  • [37] Similar efficacy and safety with LY2963016 insulin glargine compared with insulin glargine in patients with type 1 diabetes mellitus: the ELEMENT 1 study
    Pollom, R. K.
    Blevins, T.
    Dahl, D.
    Rosenstock, J.
    Huster, W. J.
    Ilag, L. L.
    Prince, M. J.
    DIABETOLOGIA, 2014, 57 : S69 - S69
  • [38] Evaluation of immunogenicity of LY2963016 insulin glargine compared with insulin glargine in patients with type 2 diabetes mellitus
    Ilag, L. L.
    Deeg, M. A.
    Huster, W. J.
    Costigan, T. M.
    Zielonka, J. S.
    Pollom, R. K.
    Prince, M. J.
    Konrad, R. J.
    DIABETOLOGIA, 2014, 57 : S397 - S398
  • [39] A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert J.
    Vlajnic, Aleksandra
    Hollander, Pricilla
    ENDOCRINE PRACTICE, 2011, 17 (03) : 395 - 403
  • [40] Intensification of type 1 diabetes Mellitus (DM 1) treatment: Efficacy of detemir as basal insulin
    Della Manna, T.
    Nakao, T.
    Savoldelli, R.
    Menezes-Filho, H.
    Steinmetz, L.
    Kuperman, H.
    Damiani, D.
    HORMONE RESEARCH, 2007, 68 : 8 - 8
12345